US 8399412
Method of treating or preventing tissue deterioration, injury or damage due to periodontal disease or disease of oral mucosa, and/or downregulating NF-kappabeta or supressing NF-kappabeta-mediated actions
granted A61KA61K38/08A61K38/2292
Quick answer
US patent 8399412 (Method of treating or preventing tissue deterioration, injury or damage due to periodontal disease or disease of oral mucosa, and/or downregulating NF-kappabeta or supressing NF-kappabeta-mediated actions) held by REGENERX BIOPHARMACEUTICALS, INC. expires Mon Mar 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERX BIOPHARMACEUTICALS, INC.
- Grant date
- Tue Mar 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K38/08, A61K38/2292, A61K8/64, A61P